Receptors, Antigen, T-Cell
"Receptors, Antigen, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (ANTIGENS, CD3). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.
MeSH Number(s)
D12.776.543.750.705.816.824
Concept/Terms
Receptors, Antigen, T-Cell- Receptors, Antigen, T-Cell
- T-Cell Antigen Receptor
- Antigen Receptor, T-Cell
- Receptor, T-Cell Antigen
- T Cell Antigen Receptor
- T-Cell Receptors
- Receptors, T-Cell
- T Cell Receptors
- T-Cell Receptor
- Receptor, T-Cell
- T Cell Receptor
- Receptors, T-Cell Antigen
- Receptors, T Cell Antigen
- T-Cell Antigen Receptors
- Antigen Receptors, T-Cell
- Antigen Receptors, T Cell
Below are MeSH descriptors whose meaning is more general than "Receptors, Antigen, T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Antigen, T-Cell".
- Receptors, Antigen, T-Cell
- Complementarity Determining Regions
- Receptor-CD3 Complex, Antigen, T-Cell
- Receptors, Antigen, T-Cell, alpha-beta
- Receptors, Antigen, T-Cell, gamma-delta
This graph shows the total number of publications written about "Receptors, Antigen, T-Cell" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Antigen, T-Cell" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 18 | 10 | 28 |
| 1994 | 14 | 12 | 26 |
| 1995 | 15 | 12 | 27 |
| 1996 | 12 | 9 | 21 |
| 1997 | 19 | 22 | 41 |
| 1998 | 19 | 14 | 33 |
| 1999 | 25 | 11 | 36 |
| 2000 | 15 | 18 | 33 |
| 2001 | 19 | 26 | 45 |
| 2002 | 20 | 27 | 47 |
| 2003 | 14 | 20 | 34 |
| 2004 | 15 | 23 | 38 |
| 2005 | 21 | 18 | 39 |
| 2006 | 18 | 23 | 41 |
| 2007 | 11 | 23 | 34 |
| 2008 | 10 | 21 | 31 |
| 2009 | 10 | 18 | 28 |
| 2010 | 10 | 16 | 26 |
| 2011 | 15 | 19 | 34 |
| 2012 | 11 | 13 | 24 |
| 2013 | 13 | 13 | 26 |
| 2014 | 14 | 22 | 36 |
| 2015 | 22 | 19 | 41 |
| 2016 | 30 | 19 | 49 |
| 2017 | 31 | 19 | 50 |
| 2018 | 35 | 31 | 66 |
| 2019 | 29 | 17 | 46 |
| 2020 | 15 | 19 | 34 |
| 2021 | 16 | 40 | 56 |
| 2022 | 23 | 47 | 70 |
| 2023 | 1 | 5 | 6 |
Below are the most recent publications written about "Receptors, Antigen, T-Cell" by people in Profiles.
-
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility. J Transl Med. 2023 Mar 15; 21(1):197.
-
Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer. Cancer Res. 2023 02 15; 83(4):613-625.
-
Finding TB vaccine antigens: follow the TCRs. Sci Immunol. 2023 02 03; 8(80):eadg8281.
-
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy. Mol Ther. 2023 Mar 01; 31(3):686-700.
-
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis. J Immunother Cancer. 2023 01; 11(1).
-
Isolation of Thymus Stromal Cells from Human and Murine Tissue. Methods Mol Biol. 2023; 2567:191-201.
-
aß T-cell receptor recognition of self-phosphatidylinositol presented by CD1b. J Biol Chem. 2023 02; 299(2):102849.
-
CARTIFAN-1: Concerning fatal adverse events with global use of chimeric antigen receptor-T-cell therapy in multiple myeloma. Eur J Cancer. 2023 Mar; 182:1-2.
-
Cytokine conjugation to enhance T cell therapy. Proc Natl Acad Sci U S A. 2023 01 03; 120(1):e2213222120.
-
Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma. Clin Cancer Res. 2022 12 15; 28(24):5368-5382.